Table 5.
n | Hp (+)%1 | Adjusted OR (95%CI) | P-value | |
TNF-1031/-857 | ||||
TT/CC2 | 169 | 58.6 | 1.07 (0.70-1.64) | 0.743 |
TC/CC2 | 104 | 63.5 | 1.38 (0.85-2.25) | 0.195 |
CC/CC2 | 12 | 41.7 | 0.44 (0.13-1.57) | 0.207 |
TT/CT2 | 84 | 59.5 | 1.06 (0.63-1.78) | 0.830 |
TC/CT2 | 27 | 51.9 | 0.89 (0.39-2.02) | 0.781 |
TT/TT2 | 14 | 21.4 | 0.15 (0.04-0.60) | 0.007 |
IL1B-511/-313 | ||||
CC/TT2 | 141 | 61.7 | 1.29 (0.83-2.01) | 0.259 |
CT/CT2 | 191 | 54.5 | 0.74 (0.48-1.13) | 0.159 |
TT/CC2 | 59 | 52.5 | 0.77 (0.43-1.39) | 0.384 |
H pylori seropositivity (%).
Each reference group represented all the other combinations of genotypes.
ORs of the groups with < 7 subjects were not analyzed: CT/TT = 4, TT/TT = 4, CC/CT = 6, TT/CC = 2, and CT/CC = 3.